Epilepsy presents differently in each person. The condition has a range of symptoms that varies. Convulsions can be one sign of epilepsy. However, people often experience epilepsy without ever having ...

Epilepsy is a common neurological disorder that affects millions of people worldwide. Characterized primarily by seizures, epilepsy can present in a variety of ways depending on the individual and the ...

TOLEDO, Ohio — November is National Epilepsy Awareness Month, and one Anthony Wayne High School senior is proving that life with epilepsy doesn’t have to hold you back. At just 17 years old, Roberto ...

SGLT-2 inhibitor use, compared with DPP-4 inhibitor use, was associated with a lower incidence of epilepsy among patients with type 2 diabetes. The use of sodium-glucose cotransporter 2 (SGLT-2) ...

Researchers caution that while the findings are promising, the observational study does not prove that GLP-1 drugs prevent ...

This is the latest study to suggest that GLP-1s, particularly semaglutide, are tied to a reduced risk for epilepsy in type 2 diabetes.

A new analysis suggests GLP 1 receptor agonists, the diabetes drugs that include semaglutide, dulaglutide and liraglutide, ...

A new analysis suggests that people with type 2 diabetes who use GLP-1 medications like Ozempic, Trulicity or Victoza may be ...

Temporal lobe epilepsy, which results in recurring seizures and cognitive dysfunction, is associated with premature aging of ...